Evidence map›Paper›PMID 41480024›Full record

ArticlemedRxiv : the preprint server for health sciences2025

Urinary pesticide profiles and liver disease risk in Thailand: a machine-learning risk-prediction model.

Daxesh P Patel, Christopher A Loffredo, Majda Haznadar, Mohammed Khan, Amelia L Parker, Benjarath Pupacdi, Siritida Rabibhadana, Panida Navasumrit, Nirush Lertprasertsuke, Anon Chotirosniramit and 14 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Daxesh P PatelLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Christopher A LoffredoGeorgetown University Medical Center, Washington, DC, USA.
Majda HaznadarLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Mohammed KhanLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Amelia L ParkerLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Benjarath PupacdiTranslational Research Unit, Chulabhorn Research Institute, Bangkok, Thailand.
Siritida RabibhadanaLaboratory of Chemical Carcinogenesis, Chulabhorn Research Institute, Bangkok, Thailand.
Panida NavasumritLaboratory of Environmental Toxicology, Chulabhorn Research Institute, Bangkok, Thailand.
Nirush LertprasertsukeDepartment of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Anon ChotirosniramitDepartment of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.
Chawalit PairojkulFaculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Vor LuviraFaculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Ake PugkhemFaculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Wattana SukeepaisarnjaroenFaculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Teerapat UngtrakulPrincess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
Thaniya SricharunratPrincess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.
Kannika PhornphutkulRajavej Hospital, Chiang Mai, Thailand.
Frank J GonzalezCancer Innovation Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Anuradha BudhuLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Chulabhorn MahidolLaboratory of Chemical Carcinogenesis, Chulabhorn Research Institute, Bangkok, Thailand.
Xin W WangLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Mathuros RuchirawatLaboratory of Environmental Toxicology, Chulabhorn Research Institute, Bangkok, Thailand.
Curtis C HarrisLaboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
TIGER-LC Consortium

Funding

Precision Medicine of CancerZIABC011492 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI HARRIS, CURTIS · 2013 to 2025
$23.2M
Intramural NIH HHS ZIA BC011492
6 · The paper itself

Abstract

Background: Building on evidence linking urinary glyphosate to chronic liver disease (CLD) and hepatocellular carcinoma (HCC), we developed urinary pesticide profiling integrated with machine learning risk prediction (MLRP) to stratify risk in high-exposure populations. Methods: We conducted a case-control study within the Thailand Initiative in Genomics and Expression Research for Liver Cancer (TIGER-LC; 2011-2016; n=593): 228 CLD, 116 HCC, and 249 controls. Eight urinary pesticides were quantified by LC-MS/MS (pendimethalin, oxadiazon, metsulfuron-methyl, butachlor, 2,4-dichlorophenoxyacetic acid [2,4-D], cypermethrin, flocoumafen, bromadiolone). A composite Pesticide Load Score (PLS), with and without glyphosate, estimated burden. Two predictive models were developed: a logistic-regression Pesticide-Informed Liver Cancer Risk Score (PILCRS) and an Extreme Gradient Boosting (XGBoost) classifier that incorporated age, sex, alcohol use, occupation, and PLS. Internal validity used 1,000 bootstrap resamples with optimism-corrected calibration. Findings: Predicted CLD probability increased from 30% in the lowest PLS quartile to over 70% in the highest, and HCC from 10% to 40% (p<0·0001). Relative estimates were consistent; the highest versus lowest quartile yielded odds ratios of 2·84 (95% CI 1·66-4·91) for CLD and 4·76 (2·30-10·29) for HCC. Cypermethrin remained independently associated. After optimism correction, both models demonstrated strong discrimination and calibration. Interpretation: This framework establishes a scalable, exposure-informed tool for liver disease prediction. Findings underscore pesticide burden as a modifiable risk factor and align with Sustainable Development Goal 3·9 and WHO-FAO priorities in low- and middle-income countries (LMICs). External validation is essential. Funding: National Institutes of Health (USA); Thailand Science Research and Innovation.

Indexed as

Chronic liver diseaseEnvironmental epidemiologyHepatocellular carcinomaLow- and middle-income countriesPesticide exposureRisk prediction modeling

Identifiers

PMID41480024
PMCPMC12754707

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.